IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 71, Issue 1, 2016, Pages 115-118

  Lucae, S ^a,c   Schmid Grendelmeier, P ^b   Wuthrich B ^b   Kraft, D ^a   Valenta, R ^a   Linhart, B ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

allergy; atopic dermatitis; cyclosporin A; IgE

Indexed keywords

ALLERGEN; AUTOANTIGEN; CELL EXTRACT; CYCLOSPORIN A; IMMUNOGLOBULIN E; PYROXYLIN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ALLERGY RAPID TEST; ANTIGEN ANTIBODY REACTION; ARTICLE; ATOPIC DERMATITIS; BLOOD SAMPLING; CASE REPORT; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLAMMATION; MALE; MIDDLE AGED; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN MANIFESTATION; SYSTEMIC THERAPY; T LYMPHOCYTE; TREATMENT RESPONSE; DERMATITIS, ATOPIC; IMMUNOLOGY; TIME FACTOR; TREATMENT OUTCOME;

ADULT; ALLERGENS; AUTOANTIGENS; CYCLOSPORINE; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 84956662881     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12711     Document Type: Article

References (20)

1. Wüthrich B, Schindler C, Leuenberger P, Ackermann-Liebrich U,. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults. Int Arch Allergy Immunol 1995; 106: 149-156.
2. Wickman M, Asarnoj A, Tillander H, Andersson N, Bergström A, Kull I, et al., MeDALL consortium. Childhood-to-adolescence evolution of IgE antibodies to pollens and plant foods in the BAMSE cohort. J Allergy Clin Immunol 2014; 133: 580-582.
3. Poulsen LK, Hummelshoj L,. Triggers of IgE class switching and allergy development. Ann Med 2007; 39: 440-456.
4. Hatzler L, Panetta V, Lau S, Wagner P, Bergmann RL, Illi S, et al., Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol 2012; 130: 894-901.
5. Westman M, Lupinek C, Bousquet J, Andersson N, Pahr S, Baar A, et al., Mechanisms for the Development of Allergies (MeDALL) consortium. Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence. J Allergy Clin Immunol 2015; 135: 1199-1206.
6. Lupinek C, Marth K, Niederberger V, Valenta R,. Analysis of serum IgE reactivity profiles with microarrayed allergens indicates absence of de novo IgE sensitizations in adults. J Allergy Clin Immunol 2012; 130: 1418-1420.
7. Niederberger V, Ring J, Rakoski J, Jager S, Spitzauer S, Valent P, et al., Antigens drive memory IgE responses in human allergy via the nasal mucosa. Int Arch Allergy Immunol 2007; 142: 133-144.
8. Linhart B, Bigenzahn S, Hartl A, Lupinek C, Thalhamer J, Valenta R, et al., Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy. J Immunol 2007; 178: 3924-3931.
9. Egger C, Horak F, Vrtala S, Valenta R, Niederberger V,. Nasal application of rBet v 1 or non-IgE-reactive T-cell epitope-containing rBet v 1 fragments has different effects on systemic allergen-specific antibody responses. J Allergy Clin Immunol 2010; 126: 1312-1315.
10. Marth K, Wollmann E, Gallerano D, Ndlovu P, Makupe I, Valenta R, et al., Persistence of IgE-associated allergy and allergen-specific IgE despite CD4+ T cell loss in AIDS. PLoS ONE 2014; 9: e97893.
11. Hanifin TM, Rajka G,. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; S2: 44-47.
12. Diepgen TL, Fartasch M, Hornstein OP,. Evaluation and relevance of atopic basic and minor features in patients with atopic dermatitis and the general population. Acta Derm Venerol (Stockh) 1989; 144: 50-54.
13. Zurbriggen B, Wüthrich B, Cachelin AB, Wili PB, Kägi MK,. Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis. A double-blind, single-centre, cross-over pilot study. Dermatology 1999; 198: 56-60.
14. Wolkerstorfer A, van de Waard FB, Spek FB, Glazenburg EJ, Mulder PG, Oranje AP,. Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies. Acta Derm Venerol 1999; 79: 356-359.
15. Natter S, Seiberler S, Hufnagl P, Binder BR, Hirschl AM, Ring J, et al., Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients. FASEB J 1998; 12: 1559-1569.
16. Valenta R, Maurer D, Steiner R, Seiberler S, Sperr WR, Valent P, et al., Immunoglobulin E response to human proteins in atopic dermatitis patients. J Invest Dermatol 1996; 107: 203-208.
17. Wiederrecht G, Lam E, Hung S, Martin M, Sigal N,. The mechanism of action of FK-506 and cyclosporin A. Ann N Y Acad Sci 1993; 696: 9-19.
18. Kinaciyan T, Natter S, Kraft D, Stingl G, Valenta R,. IgE autoantibodies monitored in a patient with atopic dermatitis under cyclosporin A treatment reflect tissue damage. J Allergy Clin Immunol 2002; 109: 717-719.
19. Brandt EB, Sivaprasad U,. Th2 cytokines and atopic dermatitis. J Clin Cell Immunol 2011; 2: 110.
20. Gauvreau GM, Boulet LP, Cockcroft DW, FitzGerald JM, Mayers I, Carlsten C, et al., OX40L blockade and allergen-induced airway responses in subjects with mild asthma. Clin Exp Allergy 2014; 44: 29-37.